Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
30 Cards in this Set
- Front
- Back
- 3rd side (hint)
Pharmacodynamics
|
what the drug does to the body.
|
pharmaco-D-ynamics
|
|
Drug properties
|
3-D in shape, solubilities (water,oil/fat), elect charges(acid/base)
***these encourage or inhib drug from going thru body and also it's effect |
what's it look like and move thru?
|
|
Drug effects: actions
|
act thru receptors; rely on lock-key fit; Must reach receptor at concentration to trigger effect; specific enough to limit other effects (SE), grouped into 2 processes
|
|
|
Therapeutic vs adverse effect:
|
Therapeutic: what trying to achieve
Adverse: (SE) what trying to avoid 1.toxic (OD,interactions) vs Idiosyncratic/allergic effects (surprise) |
|
|
Risk:Benefit Ratio
|
balance btwn probability of Tx & Adv Effects
|
|
|
Drug Receptors
|
1.macromolecular components of an organ that drug binds
2.result in change of physiologic function 3.Most are proteins on surface of cell 4.for endogenous molecules |
|
|
Agonist
|
Mimics signaling of endogenous compound
|
drug receptor interaction
|
|
Antagonist
|
Blocks normal signalling
|
|
|
Partial agonist
|
Yields an attenduated signaling (lock/key); close to fitting, but only partially; can start compound reaction
Ie. block hr getting too high, but won't go too low that you pass out |
|
|
What constitutes if there is a hypo- or hyper-reactivity with an interaction?
|
1. concentration of the drug at the receptor
2. concentration of receptor 3. function of receptors (genetically- will mafunct if not enough receptors) 4. components of resonse distal to receptor 5. Genetic variants (can now test for enzyme before giving- a drug that could kill the person if they didn't have the enzyme) |
think receptors
|
|
Pharmacokinetics
|
what the body does to the drug
Absorption Distribution Metabolism Excretion |
|
|
Therapeutic range
|
range of drug tissue concentration w/in where pahrm response is produced and adverse effects are prevented
|
|
|
Bioavailability
|
faction of administered dose that reaches circulation
|
f=.5 or 50%
|
|
First pass effect
|
absorbed through the GI tract and then gets processed by the liver; the dose that will never reach its systemic circulation due to breakdown
f=100% iv route: doesn't go through gi tract then liver. |
|
|
PgP
-definition and what inhibited by |
P-glyco-protein-
pumps the drug back into GI lumen, opposing their absorption Inhibited By: durgs Inhibition by: grapefruit juice component |
|
|
True or False:
Protein binding changes are RARELY a cause of significant interactions |
True
|
|
|
Transporter Protein: Effects
|
1. @ intestine will alter drug absorption
2. @kidneys or lier will alter drug metabolism 3. @ BBB will decrease CNS toxicity 4. @ tumor cells will decrease drug efficacy |
where are they at and what happens there?
|
|
Volume of Distribution (Vd)
definition and what it's associated with... |
A proportianlity constant relating the amt of drug in the body to the serum concentration;
Apparent volume Assoc with: 1.increasing lipophilicity (moves into fat) 2.decreasing hydrophilicity (moves into water |
|
|
Drug Metabolism primarily at what organ?
|
Liver
|
|
|
Drug excretion primarily through:
|
kidney
|
what organ?
|
|
What happens to the drug when metabolized?
|
changes/altered to make it more water soluble (polar or electrically charged) for easier elimination from the body
|
|
|
Phase I-Metabolism
|
Change in structure; by the liver
1. Oxidation: Hydroxylation- Phenytoin, APAP Dealkylation- diazepam Deamination- Amphetamine Sulfaxidaton- Chlorpromazine 2. Reduction- Sulfasalazine, Chloramphenicol 3. Hydrolysis- ASA |
3 changes- O R H
|
|
Phase II Metabolism
|
conjugation by liver; adds mol to drug
1. Glucuronidation- apap,chloramphenicol 2. Methylation- Norepi 3. Acetylation- Procainamide, Isoniazid |
|
|
True or False:
You can have phase II without undergoing phase I of metabolism. |
True
|
|
|
Cytocyhrome P450 enzyme
|
aid in oxiding reactions
|
|
|
Name cytochrome p450 enzyme abbrev:
1. cytochrome Superfamily 2. cytochrome family 3. cytochrome Subfamily 4. cytochrome Isoenzyme |
1. CYP
2. CYP 2 3. CYP 2C 4. CYP 2C19 |
|
|
Where are the CYP?
|
1. the cell-endoplasmic reticulum
2. Tissue- skin, kidneys, lungs, brain, liver, intestine |
name 2
C--- T----- |
|
Drug Elimination
|
fremoving drug from the body
|
|
|
GFR
|
describes function of the kidney; estimated by creatinine clearance (CLcr)
|
|
|
CLcr
|
m=(ml/min)=(140-age)x wt(kg)/ 72 x Scr
f= est CLcr male x 0.85 ** use IBW if obese |
|